Alterations in the glycolytic and glutaminolytic pathways after malignant transformation of rat liver oval cells

Journal of Cellular Physiology

Volumn 181, Issue 1, 1999, Pages 136-146

  Mazurek, Sybille ^a   Eigenbrodt, Erich ^a   Failing, Klaus ^a   Steinberg, Pablo ^b  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b UNIVERSITY OF POTSDAM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLUTAMIC ACID; GLUTAMINE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HEXOKINASE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; GLUCOSE INTAKE; GLYCOLYSIS; ION TRANSPORT; LIVER CELL; MALIGNANT TRANSFORMATION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CELL LINE, TRANSFORMED; GLUTAMINE; GLYCOLYSIS; HYDROLYSIS; ISOELECTRIC FOCUSING; LIVER NEOPLASMS, EXPERIMENTAL; RATS;

EID: 0032797579     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4652(199910)181:1<136::AID-JCP14>3.0.CO;2-T     Document Type: Article

References (72)

1. Bannasch P. 1996. Pathogenesis of hepatocellular carcinoma: sequential cellular, molecular, and metabolic changes. In: Boyer JL, Ockner RK, editors. Progress in Liver Diseases, Vol XIV. Philadelphia: WB Saunders Company. p 161-197.
2. Bergmeyer HU. (ed). 1974. Methoden der enzymatischen Analyse, Verlag Chemie, Vol 1 and 2. Weinheim, Bergstrasse, Germany.
3. Bissel MJ, Hatié C, Rubin H. 1972. Patterns of glucose metabolism in normal and virus-transformed chick cells in tissue culture. J Natl Cancer Inst 8:555-565.
4. Biaglow JE, Cerniglia G, Turtle S, Bakanauskas V, Stevens C, McKenna G. 1997. Effect of oncogene transformation of rat embryo cells on cellular oxygen consumption and glycolysis. Biochem Biophys Res Commun 235:739-742.
5. Board M, Humm S, Newsholme EA. 1990. Maximum activities of key enzymes of glycolysis, glutaminolysis, pentose phosphate pathway and tricarboxylic acid cycle in normal, neoplastic and suppressed cells. Biochem J 265:503-509.
6. Bouzier A-K, Goodwin R, Macouillard-Poulletier de Gannes F, Valeins H, Voisin P, Canioni P, Merle M. 1998. Compartmentation of lactate and glucose metabolism in C6 glioma cells. J Biol Chem 273:27162-27169.
7. Brand K. 1985. Glutamine and glucose metabolism during thymocyte proliferation. Pathways of glutamine and glutamate metabolism. Biochem J 228:353-361.
8. Brand K, Leibold W, Luppa P, Schoerner C, Schulz A. 1986. Metabolic alterations associated with proliferation of mitogen-activated lymphocytes and of lymphoblastoid cell lines: evaluation of glucose and glutamine metabolism. Immunobiology 173:23-34.
9. Bustamante E, Pedersen PL. 1980. Mitochondrial hexokinase of rat hepatoma cells in culture: solubilization and kinetic properties. Biochemistry 19:4972-4977.
10. Dixon WJ, editor. 1992. BMDP Statistical software manual. Berkley, Los Angeles, Oxford: University of California Press.
11. Eck H-P, Drings P, Dröge W. 1989. Plasma glutamate levels, lymphocyte reactivity and death rate in patients with bronchial carcinoma. J Cancer Res Clin Oncol 115:571-574.
12. Eigenbrodt E, Fister P, Reinacher M. 1985. New perspectives on carbohydrate metabolism in tumor cells (review). In: Beitner R, editor. Regulation of carbohydrate metabolism. Boca Raton, Florida: CRC Press Inc. II 6, p 141-179.
13. Eigenbrodt E, Gerbracht U, Mazurek S, Presek P, Friis R. 1994. Carbohydrate metabolism and neoplasia: new perspectives for diagnosis and therapy. In: Pretlow TG, Pretlow TP, editors. Biochemical and molecular aspects of selected cancers, Vol 2. San Diego: Academic Press, Inc. p 311-385.
14. 2 in the regulation of phosphometabolite pools. In: Bannasch P, Kanduc D, Papa S, Tager JM, editors. Cell growth and oncogenesis. Basel/Switzerland: Birkhäuser Verlag. p 15-30.
15. Eigenbrodt E, Kallinowski F, Ott M, Mazurek S, Vaupel P. 1998b. Pyruvate kinase and the interaction of amino acid and carbohydrate metabolism in solid tumors. Anticancer Res 18:3267-3274.
16. Evarts RP, Nagy P, Thorgeirsson SS. 1987a. A precursor-product relationship exists between oval cells and hepatocytes in rat liver. Cancinogenesis 8:1737-1740.
17. Evarts RP, Nagy P, Nakatsukasa H, Marsden E, Thorgeirsson SS. 1987b. In vivo differentiation of oval cells into hepatocytes. Cancer Res 49:1541-1547.
18. Farber E. 1984a. Cellular biochemistry of the stepwise development of cancer with chemicals: G.H.A. Clowes memorial lecture. Cancer Res 44:5463-5474.
19. Farber E. 1984b. Precancerous steps in carcinogenesis. Their physiological adaptive nature. Biochim Biophys Acta 738:171-180.
20. Fausto N. 1990. Oval cells and liver carcinogenesis: an analysis of cell lineages in hepatic tumors using oncogene transfection techniques. Prog Clin Biol Res 331:325-334.
21. Fischer G, Domingo M, Lodder D, Katz N, Reinacher M, Eigenbrodt E. 1987. Immunohistochemical demonstration of decreased L-pyruvate kinase in enzyme altered rat liver lesions produced by different carcinogenes. Virchows Arch B53:359-364.
22. Gerbracht U, Roth E, Becker K, Reinacher M, Eigenbrodt E. 1988a. A study of the activities of carbohydrate-metabolizing enzymes and the levels of carbohydrate metabolites and amino acids in normal liver and in hepatocellular carcinoma. In: Roberfroid M, Preat V, editors. Experimental hepatocarcinogenesis. New York: Plenum p 163-174.
23. Gerbracht U, Weiβe G, Schlatterer B, Reinacher M, Schulte-Hermann R, Eigenbrodt E. 1988b. Comparative study on the effect of different treatment schedules on some carbohydrate metabolizing enzyme activities in rats during hepatocarcinogenesis. In: Feo F, Pani P, Columbano A, Garcea R, editors. Chemical carcinogenesis. New York: Plenum. p 323-335.
24. Gerbracht U, Eigenbrodt E, Simile MM, Pascale RM, Gaspa L, Daino L, Seddaiu MA, De Miglio MR, Nufris A, Feo F. 1993. Effect of S-adenosyl-L-methionine on the development of preneoplastic foci and the activity of some carbohydrate metabolizing enzymes in the liver, during experimental hepatocarcinogenesis. Anticancer Res 13:1965-1972.
25. Gonzales-Mateos F, Gomez M-E, Garcia-Salguero L, Sanchez V, Aragon JJ. 1993. Inhibition of glycolysis by amino acids in ascites tumor cells. J Biol Chem 268:7809-7817.
26. Goossens V, Grooten J, Fiers W. 1996. The oxidative metabolism of glutamine A modulator of reactive oxygen intermediate-mediated cytotoxicity of tumor necrosis factor in L929 fibrosarcoma cells. J Biol Chem 271:192-196.
27. Gregory SH, Bose SK. 1977. Density-dependent changes in hexose transport, glycolytic enzyme levels, and glycolytic rates in uninfected and murine sarcoma-virus transformed rat kidney cells. Exp Cell Res 110:387-397.
28. Hacker HJ, Steinberg P, Bannasch P. 1998. Pyruvate kinase isoenzyme shift from L-type to M2-type is a late event in hepatocarcinogenesis induced in rats by a choline-deficient/DL-ethionine-supplemented diet. Carcinogenesis 19:99-107.
29. Hannigan MH, Pitot HC. 1985. Gamma-glutamyl transpeptidase: its role in hepatocarcinogenesis. Carcinogenesis 6:165-172.
30. Hayner NT, Braun L, Yaswen P, Brooks M, Fausto N. 1984. Isozyme profiles of oval cells, parenchymal cells, and biliary cells isolated by centrifugal elutriation from normal and preneoplastic livers. Cancer Res 44:332-338.
31. Hugo F, Mazurek S, Zander U, Eigenbrodt E. 1992. In vitro effect of extracellular AMP on MCF-7 breast cancer cells: inhibition of glycolysis and cell proliferation. J Cell Physiol 153:539-549.
32. Ibsen KH. 1977. Interrelationsships and functions of the pyruvate kinase isoenzymes and their variant forms: a review. Cancer Res 37:341-353.
33. Jiang B-H, Agani F, Passaniti A, Semenza GL. 1997. V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression. Cancer Res 57:5328-5335.
34. Kallinowski F, Schlenger KH, Runkel S, Kloes M, Stohrer M, Okunieff P, Vaupel P. 1989. Blood flow, metabolism, cellular microenvironment, and growth rate of human tumor xenografts. Cancer Res 49:3759-3764.
35. Katz N, Immenschuh S, Gerbracht U, Eigenbrodt E, Föllmann W, Petzinger E. 1992. Hormone-sensitive carbohydrate metabolism in rat hepatocyte-hepatoma hybrid cells. Eur J Cell Biol 57:117-123.
36. Kole HK, Resnick RJ, Van Doren M, Racker E. 1991. Regulation of 6-phosphofructo-1-kinase activity in ras-transformed rat-1 flbroblasts. Arch Biochem Biophys 286:586-590.
37. Lanks KW, Li P-W. 1988. End products of glucose and glutamine metabolism by cultured cell lines. J Cell Physiol 135:151-155.
38. Lemire JM, Shiojiri N, Fausto N. 1991. Oval cell proliferation and the origin of small hepatocytes in liver injury induced by D-galactosamine. Am J Pathol 139:535-552.
39. Maltepe E, Schmidt JV, Baunoch D, Bradfield CA, Simon MC. 1997. Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT. Nature 386:403-407.
40. Matsuno T. 1987. Bioenergetics of tumor cells: glutamine metabolism in tumor cell mitochondria. Int J Biochem, 19:303-307.
41. Mathupala SP, Rempel A, Pedersen PL. 1997. Abberant glycolytic metabolism of cancer cells: a remarkable coordination of genetic, transcriptional, post-translational, and mutational events that lead to a critical role for type II hexokinase. J Bioenerg Biomembr 29:339-343.
42. Mazurek S, Hugo H, Failing K, Eigenbrodt E. 1996. Studies on associations of glycolytic and glutaminolytic enzymes in MCF-7 cells Role of p36. J Cell Physiol 167:238-250.
43. Mazurek S, Michel A, Eigenbrodt E. 1997a. Effect of extracellular AMP on cell proliferation and metabolism of breast cancer cell lines with high and low glycolytic rates. J Biol Chem 272:4941-4952.
44. Mazurek S, Boschek CB, Eigenbrodt E. 1997b. The role of phosphometabolites in cell proliferation, energy metabolism, and tumor therapy. J Bioenerg Biomembr 29:315-330.
45. Mazurek S, Grimm H, Wilker S, Leib S, Eigenbrodt E. 1998. Metabolic characteristics of different malignant cancer cell lines. Anticancer Res 18:3275-3282.
46. McKeehan WL. 1982. Glycolysis, glutaminolysis and cell proliferation. Cell Biol Int Rep 6:635-650.
47. Newell K, Franchi A, Pouysségur J, Tannock I. 1993. Studies with glycolysis-deficient cells suggest that production of lactic acid is not the only cause of tumor acidity. Proc Natl Acad Sci USA 90:1127-1131.
48. Pack R, Heck R, Dienes HP, Oesch F, Steinberg P. 1993. Isolation, biochemical characterization, long-term culture, and phenotype modulation of oval cells from carcinogen-fed rats. Exp Cell Res 204:198-209.
49. Peterkofsky B, Prather W. 1982. Correlation between the rates of aerobic glycolysis and glucose transport, unrelated to neoplastic transformation, in a series of BALB 3T3-derived cell lines. Cancer Res 42:1809-1816.
50. Ponder KP. 1996. Analysis of liver development, regeneration, and carcinogenesis by genetic marking studies. FASEB J 10:673-684.
51. Pretlow TP, Grane RW, Goehring PL, Lapinsky AS, Pretlow TG. 1987. Examination of enzyme-altered foci with gamma-glutamyl transpeptidase, aldehyde dehydrogenase, glucose-6-phosphate dehydrogenase, and other markers in methacrylate-embedded liver. Lab Invest 56:96-100.
52. Reinacher M, Eigenbrodt E, Gerbracht U, Zenk G, Timmermann-Trosiener I, Bentley P, Waechter F, Schulte-Hermann R. 1986. Pyruvate kinase isoenzymes in altered foci and carcinoma of rat liver. Carcinogenesis 7:1351-1357.
53. Rempel A, Mathupala SP, Griffin CA, Hawkins AL, Pedersen PL. 1996. Glucose catabolism in cancer cells: amplification of the gene encoding type II hexokinase. Cancer Res 56:2468-2471.
54. +-dependent malic enzyme activity and malate-dependent pyruvate formation are progression-linked in Morris hepatomas. J Biol Chem 255:3844-3848.
55. Sauer LA, Stayman JW III, Dauchy RT. 1982. Amino acid, glucose, and lactic acid utilization in vivo by rat tumors. Cancer Res 42: 4090-4097.
56. Sebolt JS, Weber G. 1984. Negative correlation of L-glutamine concentration with proliferation rate in rat hepatomas. Life Sci 34:301-306.
57. Shim H, Dolde C, Lewis BC, Wu C-S, Dang G, Jungmann RA, Dalla-Favera R, Dang CV. 1997. c-Myc transactivation of LDH-A: implications for tumor metabolism and growth. Proc Natl Acad Sci USA 94:6658-6663.
58. Shinozuka H, Lombardi B. 1980. Synergistic effect of a choline-devoid diet and phenobarbital in promoting the emergence of foci of γ-glutamyltranspeptidase-positive hepatocytes in the liver of carcinogentreated rats. Cancer Res 40:3846-3849.
59. Sigal SH, Brill S, Fiorino AS, Reid LM. 1992. The liver as a stem cell and lineage system. Am J Physiol 263:G139-G148.
60. Stanton RC, Seifter JL, Boxer DC, Zimmermann E, Cantley LC. 1991. Rapid release of bound glucose-6-phosphate dehydrogenase by growth factors. J Biol Chem 266:12442-12448.
61. Steinberg P, Hacker HJ, Dienes HP, Oesch F, Bannasch P. 1991. Enzyme histochemical and immunohistochemical characterization of oval and parenchymal cells proliferating in livers of rats fed a choline-deficient/DL-ethionine-supplemented diet. Carcinogenesis 12:225-231.
62. Steinberg P, Steinbrecher R, Radaeva S, Schirmacher P, Dienes HP, Oesch F, Bannasch P. 1994a. Oval cell lines OC/CDE6 and OC/ CDE22 give rise to cholangiocellular and undifferentiated carcinomas after transformation. Lab Invest 71:700-709.
63. Steinberg P, Weiβe G, Eigenbrodt E, Oesch F. 1994b. Expression of L- and M2-pyruvate kinase in proliferating oval cells and cholangio-cellular lesions developing in the livers of rats fed a methyl-deficient diet. Carcinogenesis 15:125-127.
64. Steinberg P, Klingelhöffer A, Schäfer A, Wüst G, Weiβe G, Oesch F, Eigenbrodt E. 1999. Expression of pyruvate kinase M2 in preneoplastic hepatic foci of N-nitrosomorpholine-treated rats. Virchows Arch 434:213-220.
65. 31P NMR investigation of effect of 6-aminonicotinamide on metabolism of RIF-1 tumor cells in vitro. J Biol Chem 271:4113-4119.
66. Tee LBG, Kirilak Y, Huang W-H, Morgan RH, Yeoh GCT. 1994. Differentiation of oval cells into duct-like cells in preneoplastic liver of rats placed on a choline-deficient diet supplemented with ethionine. Carcinogenesis 15:2747-2756.
67. Tee LBG, Kirilak Y, Huang W-H, Smith PGJ, Morgan RH, Yeoh GCT. 1996. Dual phenotypic expression of hepatocytes and bile ductular markers in developing and preneoplastic rat liver. Carcinogenesis 17:251-259.
68. Tian W-N, Braunstein LD, Pang J, Stuhlmeier KM, Xi Q-C, Tian X, Stanton RC. 1998. Importance of glucose 6-phosphate dehydrogenase activity for cell growth. J Biol Chem 273:10609-10617.
69. Weber G, Morris, HP. 1963. Comparative biochemistry of hepatomas. III. Carbohydrate enzymes in liver tumors of different growth rates. Cancer Res 23:987-994.
70. Weber G, Stubbs M, Morris HP. 1971. Metabolism of hepatomas of different growth rates in situ and during ischemia. Cancer Res 31:2177-2183.
71. Yanagi S, Makiura S, Arai M, Matsumura K, Hirano K, Ito N, Tanaka T. 1974. Isoenzyme patterns of pyruvate kinase in various primary liver tumors induced during the process of hepatocarcinogenesis. Cancer Res 34:2283-2289.
72. Zwerschke W, Mazurek S, Massimi P, Banks L, Eigenbrodt E, Jansen-Dürr P. 1999. Modulation of pyruvate kinase type M2 by the human papillomavirus type 16 E7 oncoprotein. Proc Natl Acad Sci USA 96:1291-1296